W T Creasman|J C Weed - JoVE Visualize

Showing results (71-80 of 156) with videos related to

Pageof 16

Sort By:

Obstetrics and Gynecology|September 1, 1983

Human papilloma virus in multifocal, invasive female genital tract malignancyJ C Weed, C Lozier, S J Daniel

Obstetrics and Gynecology|November 1, 1984

Complications of low-dose heparin prophylaxis in gynecologic oncology surgeryD L Clarke-Pearson, E R DeLong, I S Synan, et al.

Gynecologic Oncology|June 1, 1995

Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot studyG L Eddy, A Manetta, R D Alvarez, et al.

Gynecologic Oncology|April 1, 1989

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H Homesley, et al.

Obstetrics and Gynecology|August 1, 1993

Gynecologic tumors in tamoxifen-treated women with breast cancerM A Seoud, J Johnson, J C Weed

Obstetrics and Gynecology|January 1, 1985

Fine-needle aspiration in gynecology: evaluation of extrapelvic lesions in patients with gynecologic malignancyK J Fortier, D L Clarke-Pearson, W T Creasman, et al.

Obstetrics and Gynecology|January 1, 1985

Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervixL C Bandy, D L Clarke-Pearson, P M Silverman, et al.

Gynecologic Oncology|August 1, 1997

Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group StudyL Williams, V L Brunetto, E Yordan, et al.

American Journal of Clinical Oncology|June 1, 1984

A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group studyH B Muss, M Slavik, B Bundy, et al.

American Journal of Clinical Oncology|June 1, 1983

Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group studyJ T Thigpen, C E Ehrlich, W T Creasman, et al.

Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:

Pageof 16

Obstetrics and Gynecology|September 1, 1983

Human papilloma virus in multifocal, invasive female genital tract malignancyJ C Weed, C Lozier, S J Daniel

Obstetrics and Gynecology|November 1, 1984

Complications of low-dose heparin prophylaxis in gynecologic oncology surgeryD L Clarke-Pearson, E R DeLong, I S Synan, et al.

Gynecologic Oncology|June 1, 1995

Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot studyG L Eddy, A Manetta, R D Alvarez, et al.

Gynecologic Oncology|April 1, 1989

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H Homesley, et al.

Obstetrics and Gynecology|August 1, 1993

Gynecologic tumors in tamoxifen-treated women with breast cancerM A Seoud, J Johnson, J C Weed

Obstetrics and Gynecology|January 1, 1985

Fine-needle aspiration in gynecology: evaluation of extrapelvic lesions in patients with gynecologic malignancyK J Fortier, D L Clarke-Pearson, W T Creasman, et al.

Obstetrics and Gynecology|January 1, 1985

Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervixL C Bandy, D L Clarke-Pearson, P M Silverman, et al.

Gynecologic Oncology|August 1, 1997

Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group StudyL Williams, V L Brunetto, E Yordan, et al.

American Journal of Clinical Oncology|June 1, 1984

A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group studyH B Muss, M Slavik, B Bundy, et al.

American Journal of Clinical Oncology|June 1, 1983

Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group studyJ T Thigpen, C E Ehrlich, W T Creasman, et al.

Pageof 16